NCT05820906 2023-12-06
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
Clinical Trials
6 trialsNCT05823987 2023-06-27
OPTIONS-05
Fudan University
Phase 2 Unknown
NCT05653180 2023-04-03
IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Unknown
NCT05781074 2023-03-24
CASTLE-08
Fudan University
Phase 2 Unknown
NCT05410197 2022-10-12
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)
Sun Yat-sen University
Phase 2 Unknown
NCT04027764 2019-07-22
Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer
Chinese PLA General Hospital
Phase 2 Unknown